We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GSK PLC 12 June 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...
GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in reg ...
GSK PLC 11 June 2024 Issued: 10 June 2024, London UK Statement: Zantac (ranitidine) litigation - GSK starts process for appeal of recent Delaware Daubert decision · Delaware Superior...
GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to ...
GSK PLC 10 June 2024 Issued: 10 June 2024, London UK Statement: Zantac (ranitidine) litigation - Kasza case GSK plc (LSE/NYSE: GSK) welcomes the plaintiff's voluntary dismissal of the...
GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its re ...
GSK PLC 10 June 2024 Issued: 7 June 2024, London UK US FDA approves expanded age indication for GSK's Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at...
GSK PLC 03 June 2024 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the...
An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it ...
GSK PLC 03 June 2024 Issued: 3 June 2024, London UK Jemperli (dostarlimab) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions